SEC Form 4 · accession 0001493152-17-010934
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Felice Schnoll-Sussman
Director
Period of report
Sep 25, 2017
Accepted (ET)
Sep 26, 2017 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.48 | Sep 25, 2017 | A | 20,000 | A | — | Sep 25, 2020 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The stock option award vests and becomes exercisable over a three-year period, in equal annual installments, subject to the reporting person's continued service with the issuer.